Daewoong Pharmaceutical-KMI Collaborate to Expand AI Electrocardiogram Testing

Daewoong Pharmaceutical announced on the 24th that it has signed an 'Artificial Intelligence (AI) Electrocardiogram (ECG) Test Solution Supply Agreement' with KMI Korea Medical Institute for the wearable arrhythmia diagnosis solution ‘MobiCare’ and the heart failure diagnosis solution ‘AiTiA LVSD’.

At the 'AI Electrocardiogram Examination Business Agreement Ceremony' held last September, Kwon Jun-myeong, CEO of Medical AI, Lee Sang-ho, Chairman of KMI Korea Medical Institute, Lee Chang-jae, CEO of Daewoong Pharmaceutical, and Lee Young-shin, CEO of Sears Technology (from left), are posing for a commemorative photo.
[Photo by Daewoong Pharmaceutical]

Traditional heart ultrasound examinations have been difficult for many people to access due to their high cost, and ECG tests have limitations due to restricted testing time. The two companies expect that cardiac examinations using MobiCare and AiTiA will serve as a turning point by improving cost-effectiveness and efficiency, thereby contributing to public health.

Accordingly, Daewoong Pharmaceutical and KMI plan to apply AI technology in the challenging areas of arrhythmia and heart failure diagnosis to provide medical services that increase early diagnosis rates. Daewoong Pharmaceutical will supply MobiCare and AiTiA to eight KMI comprehensive health screening centers nationwide and provide result data for each ECG test item along with AI interpretation results and consultation explanation materials. KMI will enhance the utilization of the newly launched arrhythmia and heart failure screening through education and promotion.

In addition to Daewoong Pharmaceutical and KMI, four companies including Sears Technology, the developer of MobiCare, and MedicalAI, the developer of AiTiA, formed a task force team following the signing of a memorandum of understanding (MOU) in September last year. They have been operating a pilot project at the KMI Jeju Center to verify the clinical effectiveness and operational process of AI-based arrhythmia and heart failure diagnostic tests.

MedicalAI’s AiTiA predicts the risk of heart failure through AI algorithms based on ECG data, enabling early diagnosis of heart failure, which was previously detected only at a significantly advanced stage. It is also described as more economical and convenient compared to existing tests.

Sears Technology, the developer of MobiCare, verified the stability of the ‘KMI specialized system’ capable of conducting ECG tests for more than 800 people simultaneously per day through the pilot project. By monitoring location control and real-time testing, it secured the stability and accuracy of the tests while diagnosing multiple arrhythmia suspicious results, proving the necessity of ‘continuous ECG testing.’

KMI, which is building a smart screening system through its own system called the 'KMI Intelligent Comprehensive Health Screening System (KICS),' plans to further strengthen the smart healthcare environment for partner companies and customers by introducing differentiated cardiac examination solutions. Since its establishment in 1985, KMI currently operates health screening centers in eight locations nationwide: three in Seoul (Gwanghwamun, Yeouido, Gangnam) and five regional centers (Suwon, Daegu, Busan, Gwangju, Jeju).

Lee Chang-jae, CEO of Daewoong Pharmaceutical, said, “The contract with KMI, a leading domestic screening specialist institution, is a meaningful first step toward early diagnosis in the areas of arrhythmia and heart failure. We will do our best to promote public health by providing dramatically improved testing solutions together with the best specialized companies in each field.” Lee Sang-ho, Chairman of KMI, also said, “We expect that the AI ECG test solution, introduced for the first time among health screening institutions, will dramatically raise the level of cardiac examinations in the screening field. We will continue to provide new value in health screening to customers by strengthening cooperation with companies that possess the best technology.”

This content was produced with the assistance of AI translation services.